Genomic alterations in breast cancer: level ofevidence for actionability
Genomic alterations in breast cancer: level ofevidence for actionability according to ESMO Scale forClinical Actionability of molecular Targets (ESCAT)
https://www.annalsofoncology.org/art...092-0/fulltext Nguyen |
All times are GMT -7. The time now is 11:02 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021